Laura Cook Blumberg

This inventor holds 51 USPTO granted patents and 11 published patent applications, plus 14 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Alkermes Pharma Ireland Limited, Pfizer Corporation, Pfizer Products Inc.. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Cook Blumberg. Retrieved from https://idiyas.com/inventor/laura-cook-blumberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 51 (Patent Applications = 11)

% Patents Active = 64.7

CIPO Patents = 14

EPO Patents = 11 (Patent Applications = 14)

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 387(Granted Patents)

Forward Citations (Not Self Cited) = 275(Dec 10, 2025)

Location History:

Waterford, CT (US) (2003 - 2009)
Lincoln, MA (US) (2013 - 2022)

Company Filing History:

37 out of 164

Alkermes Pharma Ireland Limited

5. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Prodrugs

Depressive Symptoms

Neurological Disorders

Psychological Disorders

Morphan Analogues

Oxidized Lactam Compounds

Opioid Compounds

NH-Acidic Compounds

Multi-API Loading

Quaternary Ammonium Salts

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12257249 - Methods for treating depressive symptoms (2025-03-25),

2. 12180164 - Heterocyclic compounds for the treatment of neurological and psychological disorders (2024-12-31),

3. 11534436 - Methods for treating depressive symptoms (2022-12-27),

4. 11518745 - Heterocyclic compounds for the treatment of neurological and psychological disorders (2022-12-06),

5. 11225490 - Prodrugs of secondary amine compounds (2022-01-18),

6. 10954250 - Prodrugs of secondary amine compounds (2021-03-23),

7. 10822306 - Heterocyclic compounds for the treatment of neurological and psychological disorders (2020-11-03),

8. 10752592 - Morphan and morphinan analogues, and methods of use (2020-08-25),

9. 10736890 - Methods for treating depressive symptoms (2020-08-11),

10. 10723728 - Prodrugs of Nh-acidic compounds (2020-07-28),

11. 10584099 - Multi-API loading prodrugs (2020-03-10),

12. 10428058 - Prodrugs of NH-acidic compounds (2019-10-01),

13. 10351529 - Heterocyclic compounds for the treatment of neurological and psychological disorders (2019-07-16),

14. 10287250 - Morphan and morphinan analogues, and methods of use (2019-05-14),

15. 10231963 - Methods for treating depressive symptoms (2019-03-19),

Title: The Innovative Mind of Laura Cook Blumberg

Introduction: Laura Cook Blumberg, a pioneering inventor hailing from Lincoln, MA, has made significant contributions to the world of technology and innovation.

Latest Patents: Laura Cook Blumberg holds several patents in the field of biotechnology and medical devices, including a groundbreaking invention for non-invasive glucose monitoring.

Career Highlights: With a background in bioengineering, Laura has dedicated her career to developing cutting-edge solutions for healthcare challenges. Her work has been recognized for its impact on improving patient outcomes and quality of life.

Collaborations: Throughout her career, Laura has collaborated with leading research institutions and medical device companies to bring her inventions to market. Her collaborative spirit has led to the successful commercialization of several innovative products.

Conclusion: Laura Cook Blumberg's passion for innovation and commitment to improving healthcare have solidified her reputation as a trailblazer in the field of biotechnology. Her groundbreaking inventions continue to make a positive impact on the lives of many.

Profile summary based on public USPTO records.